Wellgistics Health forms joint venture with KareRx Hub, issuing up to $2M in stock for 51% stake

Wellgistics Health, Inc.

Wellgistics holds 51% membership interest in new LLC Healthstar; Kare Rx Hub holds 49%.
Consideration of up to $2M in unregistered common stock: 1.5M shares at closing, additional shares at Wellgistics' option based on VWAP.
Combined platform (EinsteinRx, HubRx AI, KareRx digital hub) aims to reach 200,000+ patient lives.
Partner Kare PharmTech is controlled by Dr. Kiran Patel, founder of WellCare (sold for $200M) and America's 1st Choice Holdings.
Shares subject to 12-month lock-up; closing subject to due diligence and customary conditions.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Wellgistics Health, Inc. entered into Collaboration Agreement with Kare Rx Hub, LLC, Kare Pharmtech, LLC, and Healthstar Technologies, LLC valued at $2,000,000 (effective 2026-04-13).

Action: entry
Agreement: collaboration
Counterparty: Kare Rx Hub, LLC, Kare Pharmtech, LLC, and Healthstar Technologies, LLC
Value: $2,000,000
Effective: 2026-04-13

Exact text from the filing

On April 13, 2026, Wellgistics Health, Inc. (the “Company”) entered into a Collaboration Agreement (the “Collaboration Agreement”) with Kare Rx Hub, LLC (“Kare Hub”), Kare Pharmtech, LLC (“Kare Pharmtech”), and Healthstar Technologies, LLC (“Healthstar”), pursuant to which the parties agreed to collaborate through a newly formed limited liability company structure.

View on SEC.gov

84 material agreements filed in the last 30 days. Browse all material agreements →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-017895

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.